Published in J Clin Oncol on February 08, 2010
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet (2012) 7.61
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol (2012) 4.00
Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol (2011) 3.56
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet (2014) 3.17
Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell (2011) 2.87
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet (2014) 2.42
A distinct spectrum of copy number aberrations in pediatric high-grade gliomas. Clin Cancer Res (2010) 2.37
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer (2014) 2.10
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet (2014) 2.02
Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas. Neuro Oncol (2010) 2.01
Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One (2012) 1.93
Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc Natl Acad Sci U S A (2011) 1.86
Targeted therapy for BRAFV600E malignant astrocytoma. Clin Cancer Res (2011) 1.79
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. Neuro Oncol (2011) 1.64
Every amino acid matters: essential contributions of histone variants to mammalian development and disease. Nat Rev Genet (2014) 1.62
Paediatric and adult malignant glioma: close relatives or distant cousins? Nat Rev Clin Oncol (2012) 1.58
Challenging issues in pediatric oncology. Nat Rev Clin Oncol (2011) 1.56
ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents. Cancer Discov (2014) 1.52
Overcoming autopsy barriers in pediatric cancer research. Pediatr Blood Cancer (2012) 1.47
Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathol (2014) 1.46
Diffuse intrinsic pontine glioma: poised for progress. Front Oncol (2012) 1.41
Genomic aberrations in pediatric diffuse intrinsic pontine gliomas. Neuro Oncol (2011) 1.31
Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma. Cancer (2010) 1.30
Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol (2010) 1.27
Treatment of high-grade glioma in children and adolescents. Neuro Oncol (2011) 1.27
Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res (2013) 1.23
Targeting Wee1 for the treatment of pediatric high-grade gliomas. Neuro Oncol (2013) 1.15
Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathol (2013) 1.15
PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma. PLoS One (2013) 1.14
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat Rev Cancer (2014) 1.10
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas. Eur J Cancer (2010) 1.09
Diffuse intrinsic pontine glioma-current status and future strategies. Childs Nerv Syst (2011) 1.09
Childhood brain tumors: epidemiology, current management and future directions. Nat Rev Neurol (2011) 1.09
A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol (2011) 1.07
Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β. Mol Cancer Ther (2011) 1.05
PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation. Oncotarget (2011) 1.05
PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma. Brain Pathol (2013) 1.00
Pediatric high-grade glioma: biologically and clinically in need of new thinking. Neuro Oncol (2017) 0.99
A standardized autopsy procurement allows for the comprehensive study of DIPG biology. Oncotarget (2015) 0.94
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid. J Clin Oncol (2016) 0.94
Human pontine glioma cells can induce murine tumors. Acta Neuropathol (2014) 0.92
Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid. Neuro Oncol (2012) 0.92
Primary gliomatosis cerebri involving gray matter in pediatrics: a distinct entity? A multicenter study of 14 cases. Childs Nerv Syst (2013) 0.91
Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. Neuro Oncol (2014) 0.91
A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent. PLoS One (2015) 0.91
A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report. Neuro Oncol (2014) 0.90
Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas. Childs Nerv Syst (2015) 0.90
Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04). Eur J Cancer (2013) 0.89
Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma. J Neurooncol (2011) 0.88
Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma. Clin Cancer Res (2013) 0.88
The clinical, research, and social value of autopsy after any cancer death: a perspective from the Children's Oncology Group Soft Tissue Sarcoma Committee. Cancer (2011) 0.87
Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors. Pediatr Blood Cancer (2013) 0.87
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma. Neuro Oncol (2014) 0.86
Pediatric high-grade glioma: identification of poly(ADP-ribose) polymerase as a potential therapeutic target. Neuro Oncol (2011) 0.86
Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma. Front Oncol (2015) 0.86
Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays. J Mol Diagn (2011) 0.85
A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1. Neurology (2017) 0.84
Clinical outcomes and natural history of pediatric brainstem tumors: with 33 cases follow-ups. Neurosurg Rev (2012) 0.83
Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment. Biomed Res Int (2015) 0.83
ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model. Mol Cancer Ther (2016) 0.83
Postnatal growth of the human pons: a morphometric and immunohistochemical analysis. J Comp Neurol (2014) 0.83
Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy. Front Oncol (2013) 0.82
Pax3 expression enhances PDGF-B-induced brainstem gliomagenesis and characterizes a subset of brainstem glioma. Acta Neuropathol Commun (2014) 0.81
Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities. Onco Targets Ther (2013) 0.81
Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study. Int J Radiat Oncol Biol Phys (2012) 0.81
The genetic signatures of pediatric high-grade glioma: no longer a one-act play. Semin Radiat Oncol (2014) 0.80
Management of high-grade gliomas in the pediatric patient: Past, present, and future. Neurooncol Pract (2014) 0.80
B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma. J Neurooncol (2012) 0.80
Biologically targeted therapeutics in pediatric brain tumors. Pediatr Neurol (2012) 0.80
A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells. Neoplasia (2016) 0.80
Diffusion tensor histogram analysis of pediatric diffuse intrinsic pontine glioma. Biomed Res Int (2014) 0.80
Bereaved parents' intentions and suggestions about research autopsies in children with lethal brain tumors. J Pediatr (2013) 0.80
Evidence for and against regional differences in neural stem and progenitor cells of the CNS. Genes Dev (2010) 0.79
Pediatric diffuse intrinsic pontine glioma patients from a single center. Childs Nerv Syst (2012) 0.78
Distinct genetic alterations in pediatric glioblastomas. Childs Nerv Syst (2012) 0.78
Molecular characteristics of pediatric high-grade gliomas. CNS Oncol (2014) 0.78
Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts. PLoS One (2015) 0.77
Pediatric gliomas as neurodevelopmental disorders. Glia (2015) 0.77
Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma. BMC Cancer (2016) 0.77
A preclinical study demonstrating the efficacy of nilotinib in inhibiting the growth of pediatric high-grade glioma. J Neurooncol (2015) 0.76
Epigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumors. Acta Neuropathol (2014) 0.76
Toxicity evaluation of prolonged convection-enhanced delivery of small-molecule kinase inhibitors in naïve rat brainstem. Childs Nerv Syst (2014) 0.76
Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment. Curr Neuropharmacol (2017) 0.76
Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.75
Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas. Curr Neuropharmacol (2017) 0.75
The therapeutic potential of targeting the PI3K pathway in pediatric brain tumors. Oncotarget (2016) 0.75
Genomic Insights into Diffuse Intrinsic Pontine Glioma. Front Oncol (2017) 0.75
Bioinformatics analysis of the molecular mechanism of diffuse intrinsic pontine glioma. Oncol Lett (2016) 0.75
Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study. J Neurooncol (2016) 0.75
Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets. Curr Neuropharmacol (2017) 0.75
Identification of proliferative progenitors associated with prominent postnatal growth of the pons. Nat Commun (2016) 0.75
Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities. J Pediatr Hematol Oncol (2016) 0.75
Common genetic variations in cell cycle and DNA repair pathways associated with pediatric brain tumor susceptibility. Oncotarget (2016) 0.75
Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma. Front Pharmacol (2017) 0.75
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. Cancer Cell (2017) 0.75
Glioblastoma spheroids produce infiltrative gliomas in the rat brainstem. Childs Nerv Syst (2017) 0.75
New in vivo avatars of diffuse intrinsic pontine gliomas (DIPG) from stereotactic biopsies performed at diagnosis. Oncotarget (2017) 0.75
Toxicity evaluation of convection-enhanced delivery of small-molecule kinase inhibitors in naïve mouse brainstem. Childs Nerv Syst (2015) 0.75
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
Medulloblastoma comprises four distinct molecular variants. J Clin Oncol (2010) 8.06
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell (2012) 6.07
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol (2012) 4.00
Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol (2006) 3.68
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol (2014) 3.21
Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature (2012) 2.96
Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med (2011) 2.93
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology (2011) 2.86
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol (2013) 2.82
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol (2011) 2.53
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. Lancet Oncol (2013) 2.34
Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol (2012) 2.34
Discovery-based science education: functional genomic dissection in Drosophila by undergraduate researchers. PLoS Biol (2005) 2.33
Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol (2004) 2.07
Genome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas. Neuro Oncol (2009) 2.04
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathol (2011) 2.01
Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell (2009) 1.92
Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol (2012) 1.88
Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations. J Clin Oncol (2010) 1.74
Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol (2005) 1.71
Brain biopsy in children with primary small-vessel central nervous system vasculitis. Ann Neurol (2010) 1.70
Quantitative image analysis of immunohistochemical stains using a CMYK color model. Diagn Pathol (2007) 1.70
Diffuse intrinsic brainstem tumors in neonates. Report of two cases. J Neurosurg Pediatr (2008) 1.69
Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol (2013) 1.68
Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study. Lancet Neurol (2010) 1.66
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. Neuro Oncol (2011) 1.64
KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene (2005) 1.64
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56
Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation (2008) 1.50
BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma. Clin Cancer Res (2011) 1.49
Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: correlation with IQ. Neuro Oncol (2006) 1.48
Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology (2008) 1.47
Favorable outcome with conservative treatment for children with low grade brainstem tumors. Pediatr Blood Cancer (2011) 1.46
Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathol (2014) 1.46
Genomewide clonal analysis of lethal mutations in the Drosophila melanogaster eye: comparison of the X chromosome and autosomes. Genetics (2007) 1.44
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol (2013) 1.43
Association between radiographic Wallerian degeneration and neuropathological changes post childhood stroke. Dev Med Child Neurol (2012) 1.42
SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings. Pediatr Blood Cancer (2014) 1.41
A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res (2004) 1.41
White matter growth as a mechanism of cognitive development in children. Neuroimage (2006) 1.40
Gonadotropin-regulated testicular RNA helicase (GRTH/Ddx25) is essential for spermatid development and completion of spermatogenesis. Proc Natl Acad Sci U S A (2004) 1.40
De-escalation of therapy for pediatric medulloblastoma: trade-offs between quality of life and survival. Pediatr Blood Cancer (2014) 1.39
Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma. J Neurooncol (2007) 1.38
In response to "Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low grade glioma". Support Care Cancer (2011) 1.38
Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas. Clin Cancer Res (2011) 1.35
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol (2013) 1.35
Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proc Natl Acad Sci U S A (2013) 1.33
Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Acta Neuropathol (2012) 1.33
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol (2014) 1.28
Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol (Lausanne) (2012) 1.28
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol (2012) 1.27
Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients. J Clin Invest (2011) 1.27
Hyaluronan and CD44 antagonize mitogen-dependent cyclin D1 expression in mesenchymal cells. J Cell Biol (2007) 1.25
Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma. J Clin Oncol (2006) 1.25
Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma. Int J Radiat Oncol Biol Phys (2005) 1.24
A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours. Eur J Cancer (2009) 1.24
Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor. Am J Surg Pathol (2009) 1.23
Fertility and taxon-specific sperm binding persist after replacement of mouse sperm receptors with human homologs. Dev Cell (2003) 1.17
Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas. Clin Cancer Res (2003) 1.17
Quality of health information on the Internet in pediatric neuro-oncology. Neuro Oncol (2006) 1.17
Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells. Cancer Res (2005) 1.16
GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model. Proc Natl Acad Sci U S A (2007) 1.15
A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas. J Exp Med (2011) 1.13
Imaging findings in primary intracranial atypical teratoid/rhabdoid tumors. Pediatr Radiol (2005) 1.13
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol (2012) 1.12
Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma. Ann Neurol (2014) 1.12
Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event. Cancer Genet Cytogenet (2009) 1.12
Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals. CMAJ (2011) 1.10
Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children. Cancer Res (2013) 1.10